Director Market Access UK & Ireland

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.

We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.

The UK & Ireland Market Access Director will be responsible for leading pricing, reimbursement, market access, and policy activities across the UK & Ireland, and execution across all payer and distribution channels. More broadly, the UK MA Director will be a dotted-line member of the global argenx Market Access team, supporting global market access initiatives and working in close collaboration with other functions and select local-country teams.

• Develop innovative UK & Ireland pricing and access strategies that are of high quality, based on value delivered and that are fit for purpose.
• Have deep country-level understanding of UK payer needs, decision-making approaches, strategies, and country reimbursement stakeholders and influencers.
• External engagement: Partner with the broader UK & Ireland life sciences ecosystems (NICE, SMC, NCPE, MHRA, Westminster, etc.) and industry groups (e.g. EMG).
• Collaborate with the UK Senior Leadership Team on the local pricing & reimbursement processes in the UK & Ireland.
• Coordinate the negotiation strategy for UK & Ireland, with a clearly defined negotiation approach, in close collaboration with the UK Senior Leadership Team and other functions as needed.
• Establish and maintain personal relationships with select payers, advisors, key opinion leaders and other stakeholders.
• Support the development of health economic and outcomes analyses (CEA, BIA, burden of disease, etc.) required for access, working in collaboration with internal cross-functional teams in medical affairs, evidence generation, HEOR and R&D.
• Develop compliant communication tools to be used in discussions with payers.
• Leads internal & external providers to ensure that Market Access deliverables are suitable for purpose & available in a timely fashion.
• Evaluates market access & P&R environmental developments.

• Strong cross-functional business partnership. Ability to work collaboratively and effectively together within cross-functional teams and networks.
• Ability to grasp highly technical concepts and to work within a deeply scientific environment.
• Exceptional learning agility, demonstrated by advancement in prior roles/companies.
• Direct experience negotiating with payers and securing positive HTA outcomes in the UK (NICE / SMC) and Ireland (NCPE).
• Experience working within launch and commercialisation teams for therapies in the orphan and rare disease space in the UK.
• First-rate analytical ability, with a track record of using data to inform decision-making.
• Is agile and demonstrates adaptability, comfort with ambiguity, trust-building, and resilience.
• Derives energy from operating in a dynamic, complex, fast-moving, and frequently changing business environment.
• Demonstrable experience with project management, proactive planning, priority setting, and securing alignment.
• Drives toward outcomes; ambitious, inquisitive naturally, a quick study, with demonstrated eagerness to continuously learn, self-improve and develop.
• Passionate and prepared to lead and contribute to our culture, which is driven by our corporate values of co-creation, innovation, empowerment, excellence, and humility.

• 7+ years of relevant industry experience in biotech/pharma.
• 5+ years Market Access & Pricing experience specifically involving rare disease / specialty drug launches in the UK.

• Regular Travel Required.
• Hybrid – 2 days per week in the Gerrards Cross office, with the remaining days worked remotely.

This job is eligible to participate in our short-term and long-term incentives program. At argenx, all applicants are welcomed in an inclusive environment. They will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics.